Updated:
Skyline Ventures
Skyline Ventures is a healthcare-focused investment firm founded in 1997. Its professionals hold MD or PhD degrees and specialize in small molecule and protein...
Skyline Ventures
Skyline Ventures is a healthcare-focused investment firm founded in 1997. Its professionals hold MD or PhD degrees and specialize in small molecule and protein therapeutics, medical devices, diagnostics, and life science research technologies. The firm's latest fund, Skyline V, has $350 million in committed capital and targets 15-18 portfolio companies.
General information
Firm type
Venture Capital
Year founded
1997
Location
Region
North America
Country
United States
City
Palo Alto
Corporate office
Palo Alto, CA, United States
Principals
John Freund
Managing Director
Sector focus
Frequently asked questions
Who runs investment decisions at Skyline Ventures?
John Freund, a Harvard-trained physician and former Acuson executive, co-founded the firm and serves as Managing Director. The partnership is built around physician-investors with clinical and product-development operating experience, meaning investment decisions are made by partners with direct practice or device-industry backgrounds rather than solely by career finance professionals.
What is a notable exit from Skyline's portfolio?
Acclarent, an ENT surgical device company backed by Skyline, was acquired by Johnson & Johnson's Ethicon unit. The deal validated Skyline's approach of backing specialist surgical-device platforms in concentrated markets. Other realized positions include Xoft, which developed intraoperative radiation therapy technology.
How does Skyline Ventures compare to larger healthcare venture platforms?
Skyline has maintained a deliberately lean structure and concentrated portfolio model, operating with a small team of physician-investors rather than building a large multi-sector platform. Unlike generalist Bay Area firms that added healthcare practices over time, Skyline has been exclusively healthcare-focused since its 1997 founding and has not expanded into growth equity, public markets, or non-healthcare sectors.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: